On the stock market since 2010, it operates in the world of health and science. It has 8,867 employees. Now — the numbers.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
No real growth (4% a year). Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
The stock trades 49% below its peak. The market has trimmed its expectations for the company.
It pays out $0.12 per share each year — regular cash for whoever holds the stock.
A loss of $1.1B against $43.4B in annual sales. And on top of that, sales fell from the year before.
Since the drop from its peak, buyer appetite hasn’t come back. Council score: 0/10.
On our five-subject report card, APNHF sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: APNHF has solid sales but closed last year at a loss. The road back to profit runs through spending discipline.